Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medibank PvtASX:MPL -0.79%79 Cash-to-Debt is 1.65 as of Dec. 2025, which is 100% below its 10-year median of 10,000.00. GuruFocus rates ASX:MPL with a GF Score™ of 79/100 and a GF Value™ of A$4.49 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 503 Insurance companies, Medibank Pvt ranks worse than 53.08% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Medibank Pvt's cash to debt ratio for the quarter that ended in Dec. 2025 was 1.65.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Medibank Pvtcould pay off its debt using the cash in hand for the quarter that ended in Dec. 2025.
The historical rank and industry rank for Medibank Pvt's Cash-to-Debt or its related term are showing as below:
ASX:MPL'
s Cash-to-Debt Range Over the Past 10 Years
Min: 1.65 Med: No Debt Max: No Debt
Current: 1.65
During the past 11 years, Medibank Pvt's highest Cash to Debt Ratio was No Debt. The lowest was 1.65. And the median was No Debt.
ASX:MPL's Cash-to-Debt is ranked worse than 53.08% of 503
companies
in the Insurance industry
Industry Median: 1.93
vs ASX:MPL: 1.65
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Medibank Pvt Cash-to-Debt Related Terms
Medibank Pvt Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Medibank Pvt's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Insurance - Specialty subindustry, Medibank Pvt's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medibank Pvt Cash-to-Debt vs Insurance Industry
For the Insurance industry and Financial Services sector, Medibank Pvt's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Medibank Pvt's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medibank Pvt (ASX:MPL) has a Cash-to-Debt of 1.65 as of Dec. 2025. This is 100% below median its historical median of 10,000.00. Over the past decade, Medibank Pvt's Cash-to-Debt has ranged from 1.65 to 10,000.00. According to the industry distribution chart, Medibank Pvt ranks #267 out of 503 companies in the Insurance industry, placing it in the top 53.1%.
Is Medibank Pvt's Cash-to-Debt too high?
Medibank Pvt's current Cash-to-Debt of 1.65 is 100% below median its 10-year median of 10,000.00. Over the past 10 years, this metric has ranged from a low of 1.65 to a high of 10,000.00. The Insurance industry median Cash-to-Debt is 1.93. Medibank Pvt's value of 1.65 is 14.5% below this industry median. Based on the distribution chart, Medibank Pvt ranks #267 out of 503 companies in the Insurance industry, which is below the industry midpoint. Overall, Medibank Pvt has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medibank Pvt's Cash-to-Debt compare to FNF and AXS?
According to the Insurance industry distribution chart, Medibank Pvt ranks #267 out of 503 companies for Cash-to-Debt. This places Medibank Pvt in the lower half of its industry. The industry median Cash-to-Debt is 1.93. Medibank Pvt's value of 1.65 is 14.5% below this benchmark. Historically, Medibank Pvt's own Cash-to-Debt has ranged from 1.65 to 10,000.00 over the past decade. While the company's 10-year median is 10,000.00 vs. the industry median of 1.93, Medibank Pvt has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for an Insurance company?
The median Cash-to-Debt among Insurance companies is 1.93, based on 503 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medibank Pvt's current Cash-to-Debt of 1.65 is 14.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Insurance industry, the median Cash-to-Debt is 1.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medibank Pvt's current Cash-to-Debt is 1.65, which is 100% below median its own 10-year median of 10,000.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medibank Pvt stock overvalued right now?
Based on GuruFocus' analysis, Medibank Pvt (ASX:MPL) is currently considered Modestly Overvalued. The stock's GF Value™ is A$4.49, compared to a current price of A$5.05 — trading 12.5% above its estimated fair value. The current Cash-to-Debt is 1.65, which is 100% below median its 10-year median of 10,000.00 and 14.5% below the Insurance industry median of 1.93. Medibank Pvt's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Medibank Pvt (ASX:MPL), the current Cash-to-Debt is 1.65 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medibank Pvt (ASX:MPL) Overvalued in 2026?
Based on GuruFocus' analysis, Medibank Pvt stock appears to be overvalued.
The current stock price of A$5.05 is trading 12.5% above its estimated GF Value™ of A$4.49.
GuruFocus considers Medibank Pvt to be Modestly Overvalued.
Key valuation signals for ASX:MPL:
Cash-to-Debt: 1.65 (100% below median its 10-year median of 10,000.00)
GF Value™: A$4.49 vs. price of A$5.05 (12.5% above fair value)
Industry Position: 14.5% below the Insurance median (#267 of 503)
No single metric tells the full story. See the ASX:MPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and Ahm, cover around 5 million people. Medibank and Australia's fourth-largest health fund, NIB Holdings, are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
79GF Score
Get the complete analysis for ASX:MPL
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:MPL has been successfully added to your 
